Iron metabolism in end stage renal failure: Rationale for re-evaluation of parenteral iron therapy

Orson W. Moe, Miguel Vazquez, Mariusz Kielar

Research output: Contribution to journalReview article

4 Scopus citations


Purpose of Review: In this article we will examine the basis for using chronic high dose parenteral iron therapy in dialysis patients. Recent findings: There are increasing data that dialysis patients fare better in many respects if they have higher hematocrit values although the real optimal hematocrit has not been defined. There is an increasing tendency to use parenteral iron to achieve this goal. Summary: Although parenteral iron achieves seemingly favourable short results, there are no data for its safety in the long term. On the contrary, there are reasons to suggest possible iron overload with chronic use.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalCurrent opinion in nephrology and hypertension
Issue number2
StatePublished - Mar 1 2003



  • Anaemia
  • Iron toxicity
  • Parenteral iron
  • Renal failure

ASJC Scopus subject areas

  • Internal Medicine
  • Nephrology

Cite this